Physician profile
Danielle Mclean
NPI 1780453068
$1,390.94
in general payments reported to CMS, 2019-2025
20 companies · $590 in 2025
The $590 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $801 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,390.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $211.91 | 2024-2025 | Gemtesa |
| Endo USA, INC. | $203.00 | 2024-2025 | Xiaflex |
| Abbvie INC. | $189.60 | 2024-2025 | |
| Janssen Biotech, INC. | $162.83 | 2024-2025 | Erleada |
| Abc Home Medical Supply, INC. | $94.08 | 2025 | |
| Urogen Pharma, INC. | $77.08 | 2024 | |
| Progenics Pharmaceuticals, INC. | $57.64 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $55.07 | 2024 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $52.28 | 2024-2025 | Provenge |
| Sun Pharmaceutical Industries INC. | $43.24 | 2024-2025 | |
| Blue Earth Diagnostics | $42.14 | 2024-2025 | Posluma |
| Boston Scientific Corporation | $33.17 | 2024-2025 | Upsylon, Lynx System |
| Immunitybio, INC. | $26.48 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.29 | 2025 | |
| Endo Pharmaceuticals INC. | $24.03 | 2024 | Xiaflex |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $20.94 | 2025 | Xyosted |
| Medtronic, INC. | $20.85 | 2024 | Interstim |
| Pfizer INC. | $19.73 | 2024 | |
| Astellas Pharma US INC | $16.41 | 2025 | Xtandi |
| Verity Pharmaceuticals INC. | $15.17 | 2025 | Trelstar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Mclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.